Elevated soluble CD30 characterizes patients with hepatitis C virus-induced liver allograft cirrhosis

Ankit Bharat1, Kishore Narayanan, Anjali Golocheikine

  • 1Department of Surgery, Washington University School of Medicine, St. Louis, MO 63110, USA.

Transplantation
|January 1, 2008
PubMed

Insights

Hepatitis C virus recurrence post-transplant accelerates cirrhosis. A lack of Th1 immunity and elevated soluble CD30 (sCD30) indicate higher cirrhosis risk in liver transplant patients.

Area of Science:

  • Immunology
  • Hepatology
  • Transplantation

Background:

  • Hepatitis C virus (HCV) recurrence post-orthotopic liver transplantation (OLT) accelerates allograft cirrhosis.
  • Current biochemical markers for monitoring HCV progression lack specificity and sensitivity.

Purpose of the Study:

  • Investigate HCV-specific immunity (T-helper cell responses) and serum soluble CD30 (sCD30) levels.
  • Determine association between immune profiles, sCD30, and allograft cirrhosis in OLT recipients.

Main Methods:

  • Compared HCV-specific CD4 T(h1) (IFN-gamma) and T(h2) (IL-5) cell frequencies in patients with and without allograft cirrhosis.
  • Measured serum levels of soluble CD30 (sCD30) in both patient groups.

Main Results:

  • Patients with hepatic inflammation but no cirrhosis (HIN) showed higher interferon (IFN)-gamma and T(h1) cells.
  • Patients with hepatic cirrhosis (HFC) exhibited higher interleukin (IL)-5 and T(h2) cells.
  • Significantly elevated sCD30 levels were observed in HFC patients compared to HIN patients.

Conclusions:

  • A deficiency in Th1-type CD4 T cell responses is linked to HCV-induced allograft cirrhosis.
  • Serum sCD30 may serve as a novel biomarker for monitoring hepatic cirrhosis in HCV-infected liver transplant recipients.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...